Gerald Hanks

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

United States

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Khor Li-Yan; Bae Kyounghwa; Paulus Rebecca; Al-Saleem Tahseen; Hammond M Elizabeth; Grignon David J; Che Mingxin; Venkatesan Varagur; Byhardt Roger W; Rotman Marvin; Hanks Gerald E; Sandler Howard M; Pollack Alan
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Smith Matthew R
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Smith Matthew R
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gerald Hanks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Khor Li-Yan; Bae Kyounghwa; Paulus Rebecca; Al-Saleem Tahseen; Hammond M Elizabeth; Grignon David J; Che Mingxin; Venkatesan Varagur; Byhardt Roger W; Rotman Marvin; Hanks Gerald E; Sandler Howard M; Pollack Alan
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3177-84.
2009: Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Smith Matthew R
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):92-9.
2008: Efstathiou Jason A; Bae Kyounghwa; Shipley William U; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Smith Matthew R
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.
European urology 2008;54(4):816-23.
2008: Smith Matthew R; Bae Kyounghwa; Efstathiou Jason A; Hanks Gerald E; Pilepich Miljenko V; Sandler Howard M; Shipley William U
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4333-9.
2008: Horwitz Eric M; Bae Kyounghwa; Hanks Gerald E; Porter Arthur; Grignon David J; Brereton Harmar D; Venkatesan Varagur; Lawton Colleen A; Rosenthal Seth A; Sandler Howard M; Shipley William U
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2497-504.
2007: Che Mingxin; DeSilvio Michelle; Pollack Alan; Grignon David J; Venkatesan Varagur Mohan; Hanks Gerald E; Sandler Howard M;
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202.
International journal of radiation oncology, biology, physics 2007;69(4):1117-23.
2007: Khor Li-Yan; Bae Kyounghwa; Pollack Alan; Hammond M Elizabeth H; Grignon David J; Venkatesan Varagur M; Rosenthal Seth A; Ritter Mark A; Sandler Howard M; Hanks Gerald E; Shipley William U; Dicker Adam P
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
The lancet oncology 2007;8(10):912-20.
2007: Eade Thomas N; Hanlon Alexandra L; Horwitz Eric M; Buyyounouski Mark K; Hanks Gerald E; Pollack Alan
What dose of external-beam radiation is high enough for prostate cancer?
International journal of radiation oncology, biology, physics 2007;68(3):682-9.
2007: Khor Li Yan; Moughan Jennifer; Al-Saleem Tahseen; Hammond Elizabeth H; Venkatesan Varagur; Rosenthal Seth A; Ritter Mark A; Sandler Howard M; Hanks Gerald E; Shipley William U; Pollack Alan
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3585-90.
2006: Valicenti Richard K; DeSilvio Michelle; Hanks Gerald E; Porter Arthur; Brereton Harmar; Rosenthal Seth A; Shipley William U; Sandler Howard M;
Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02.
International journal of radiation oncology, biology, physics 2006;66(4):1064-71.
2005: Horwitz Eric M; Thames Howard D; Kuban Deborah A; Levy Larry B; Kupelian Patrick A; Martinez Alvaro A; Michalski Jeffrey M; Pisansky Thomas M; Sandler Howard M; Shipley William U; Zelefsky Michael J; Hanks Gerald E; Zietman Anthony L
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.
The Journal of urology 2005;173(3):797-802.
2004: Kramer Noel M; Horwitz Eric M; Uzzo Robert G; Hanlon Alexandra L; Hanks Gerald E
Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapy.
BJU international 2004;94(1):59-62.
2004: Pollack A; DeSilvio M; Khor L-Y; Li R; Al-Saleem T I; Hammond M E; Venkatesan V; Lawton C A; Roach M; Shipley W U; Hanks G E; Sandler H M
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2133-40.
2004: Pollack Alan; Hanlon Alexandra L; Horwitz Eric M; Feigenberg Steven J; Uzzo Robert G; Hanks Gerald E
Prostate cancer radiotherapy dose response: an update of the fox chase experience.
The Journal of urology 2004;171(3):1132-6.
2004: Hanlon Alexandra L; Horwitz Eric M; Hanks Gerald E; Pollack Alan
Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer.
International journal of radiation oncology, biology, physics 2004;58(1):43-52.
2003: Hanks Gerald E; Pajak Thomas F; Porter Arthur; Grignon David; Brereton Harmart; Venkatesan Varagur; Horwitz Eric M; Lawton Colleen; Rosenthal Seth A; Sandler Howard M; Shipley William U;
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3972-8.
2003: Pollack Alan; Hanlon Alexandra L; Movsas Benjamin; Hanks Gerald E; Uzzo Robert; Horwitz Eric M
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy.
International journal of radiation oncology, biology, physics 2003;57(1):19-23.
2003: Buyyounouski Mark K; Horwitz Eric M; Hanlon Alexandra L; Uzzo Robert G; Hanks Gerald E; Pollack Alan
Positive prostate biopsy laterality and implications for staging.
Urology 2003;62(2):298-303.
2003: Horwitz Eric M; Uzzo Robert G; Hanlon Alexandra L; Greenberg Richard E; Hanks Gerald E; Pollack Alan
Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone.
The Journal of urology 2003;169(6):2153-7; discussion 2157-9.
2003: Uzzo Robert G; Pinover Wayne H; Horwitz Eric M; Parlanti Alicia; Mazzoni Susan; Raysor Susan; Mirchandani Ila; Greenberg Richard E; Pollack Alan; Hanks Gerald E; Watkins-Bruner Deborah
Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Urology 2003;61(4):754-9.
2003: Horwitz Eric M; Mitra Raj K; Uzzo Robert G; Das Indra J; Pinover Wayne H; Hanlon Alexandra L; McNeeley Shawn W; Hanks Gerald E
Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;66(2):173-9.
2003: Pinover Wayne H; Horwitz Eric M; Hanlon Alexandra L; Uzzo Robert G; Hanks Gerald E
Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy.
Cancer 2003;97(4):1127-33.
2003: Chism Derek B; Horwitz Eric M; Hanlon Alexandra L; Pinover Wayne H; Mitra Raj K; Hanks Gerald E
Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement.
International journal of radiation oncology, biology, physics 2003;55(1):71-7.
2002: Mah Dennis; Steckner Michael; Palacio Elizabeth; Mitra Raj; Richardson Theresa; Hanks Gerald E
Characteristics and quality assurance of a dedicated open 0.23 T MRI for radiation therapy simulation.
Medical physics 2002;29(11):2541-7.
2002: Movsas Benjamin; Chapman J Donald; Hanlon Alexandra L; Horwitz Eric M; Greenberg Richard E; Stobbe Corinne; Hanks Gerald E; Pollack Alan
Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings.
Urology 2002;60(4):634-9.
2002: Mah Dennis; Freedman Gary; Milestone Bart; Hanlon Alexandra; Palacio Elizabeth; Richardson Theresa; Movsas Benjamin; Mitra Raj; Horwitz Eric; Hanks Gerald E
Measurement of intrafractional prostate motion using magnetic resonance imaging.
International journal of radiation oncology, biology, physics 2002;54(2):568-75.
2002: Hanks Gerald E; Hanlon Alexandra L; Epstein Barry; Horwitz Eric M
Dose response in prostate cancer with 8-12 years' follow-up.
International journal of radiation oncology, biology, physics 2002;54(2):427-35.
2002: Mah Dennis; Steckner Michael; Hanlon Alexandra; Freedman Gary; Milestone Bart; Mitra Raj; Shukla Himu; Movsas Benjamin; Horwitz Eric; Väisänen Pasi P; Hanks Gerald E
MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plans.
International journal of radiation oncology, biology, physics 2002;53(3):757-65.
2002: Hanlon Alexandra L; Diratzouian Hasmik; Hanks Gerald E
Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer.
International journal of radiation oncology, biology, physics 2002;53(2):297-303.
2002: Price Robert A; Hanks Gerald E; McNeeley Shawn W; Horwitz Eric M; Pinover Wayne H
Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method.
International journal of radiation oncology, biology, physics 2002;53(1):236-43.
2002: Kaminski Joseph M; Hanlon Alexandra L; Horwitz Eric M; Pinover Wayne H; Mitra Raj K; Hanks Gerald E
Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control.
International journal of radiation oncology, biology, physics 2002;52(4):888-92.
2002: Diefenbach Michael A; Dorsey Jenevie; Uzzo Robert G; Hanks Gerald E; Greenberg Richard E; Horwitz Eric; Newton Fredrick; Engstrom Paul F
Decision-making strategies for patients with localized prostate cancer.
Seminars in urologic oncology 2002;20(1):55-62.
2001: Winter D L; Hanlon A L; Raysor S L; Watkins-Bruner D; Pinover W H; Hanks G E; Tricoli J V
Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer.
Urology 2001;58(4):614-8.
2001: Movsas B; Chapman J D; Hanlon A L; Horwitz E M; Pinover W H; Greenberg R E; Stobbe C; Hanks G E
Hypoxia in human prostate carcinoma: an Eppendorf PO2 study.
American journal of clinical oncology 2001;24(5):458-61.
2001: Horwitz E M; Hanlon A L; Pinover W H; Anderson P R; Hanks G E
Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.
Cancer 2001;92(5):1281-7.
2001: Mah D; Freedman G; Movsas B; Hanlon A; Mitra R; Horwitz E; Pinover W; Iyer R; Hanks G E
To move or not to move: measurements of prostate motion by urethrography using MRI.
International journal of radiation oncology, biology, physics 2001;50(4):947-51.
2001: Hanlon A L; Pinover W H; Horwitz E M; Hanks G E
Patterns and fate of PSA bouncing following 3D-CRT.
International journal of radiation oncology, biology, physics 2001;50(4):845-9.
2001: Hanks G E; Hanlon A L; Horwitz E M
Evidence for cure of 'young' men with prostate cancer.
Oncology (Williston Park, N.Y.) 2001;15(5):563-7; discussion 571-4.
2001: Cvetkovic D; Movsas B; Dicker A P; Hanlon A L; Greenberg R E; Chapman J D; Hanks G E; Tricoli J V
Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer.
Urology 2001;57(4):821-5.
2001: Horwitz E M; Winter K; Hanks G E; Lawton C A; Russell A H; Machtay M
Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy.
International journal of radiation oncology, biology, physics 2001;49(4):947-56.
2001: Lawton C A; Winter K; Murray K; Machtay M; Mesic J B; Hanks G E; Coughlin C T; Pilepich M V
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.
International journal of radiation oncology, biology, physics 2001;49(4):937-46.
2001: Hanlon A L; Watkins Bruner D; Peter R; Hanks G E
Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.
International journal of radiation oncology, biology, physics 2001;49(1):51-9.
2001: Chapman J D; Schneider R F; Urbain J L; Hanks G E
Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation.
Seminars in radiation oncology 2001;11(1):47-57.
2000: Anderson P R; Hanlon A L; Horwitz E; Pinover W; Hanks G E
Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy.
Cancer 2000;89(12):2565-9.
2000: Movsas B; Chapman J D; Greenberg R E; Hanlon A L; Horwitz E M; Pinover W H; Stobbe C; Hanks G E
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study.
Cancer 2000;89(9):2018-24.
2000: Pinover W H; Hanlon A L; Horwitz E M; Hanks G E
Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer.
International journal of radiation oncology, biology, physics 2000;47(3):649-54.
2000: Katz A; Eifel P J; Moughan J; Owen J B; Mahon I; Hanks G E
Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study.
International journal of radiation oncology, biology, physics 2000;47(2):443-50.
2000: Hanlon A L; Hanks G E
Failure patterns and hazard rates for failure suggest the cure of prostate cancer by external beam radiation.
Urology 2000;55(5):725-9.
2000: Hanks G E; Hanlon A L; Pinover W H; Horwitz E M; Price R A; Schultheiss T
Dose selection for prostate cancer patients based on dose comparison and dose response studies.
International journal of radiation oncology, biology, physics 2000;46(4):823-32.
2000: Hanlon A L; Hanks G E
Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology.
International journal of radiation oncology, biology, physics 2000;46(3):559-66.
2000: Coia L R; Minsky B D; Berkey B A; John M J; Haller D; Landry J; Pisansky T M; Willett C G; Hoffman J P; Owen J B; Hanks G E
Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):455-62.
2000: Lattanzi J; McNeeley S; Hanlon A; Schultheiss T E; Hanks G E
Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer.
Urology 2000;55(1):73-8.
2000: Lattanzi J; McNeeley S; Donnelly S; Palacio E; Hanlon A; Schultheiss T E; Hanks G E
Ultrasound-based stereotactic guidance in prostate cancer--quantification of organ motion and set-up errors in external beam radiation therapy.
Computer aided surgery : official journal of the International Society for Computer Aided Surgery 2000;5(4):289-95.
1999: Horwitz E M; Hanlon A L; Pinover W H; Hanks G E
The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1999;45(5):1219-25.
1999: Coia L R; Gunderson L L; Haller D; Hoffman J; Mohiuddin M; Tepper J E; Berkey B; Owen J B; Hanks G E
Outcomes of patients receiving radiation for carcinoma of the rectum. Results of the 1988-1989 patterns of care study.
Cancer 1999;86(10):1952-8.
1999: Tricoli J V; Winter D L; Hanlon A L; Raysor S L; Watkins-Bruner D; Pinover W H; Hanks G E
Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer.
Urology 1999;54(1):178-82.
1999: Freedman G M; Negendank W G; Hudes G R; Shaer A H; Hanks G E
Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer.
Urology 1999;54(1):118-23.
1999: Coia L R; Minsky B D; John M J; Haller D G; Landry J; Pisansky T M; Willett C G; Hoffman J P; Berkey B A; Owen J B; Hanks G E
The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care Study.
Cancer 1999;85(12):2499-505.
1999: Hanks G E; Hanlon A L; Pinover W H; Horwitz E M; Schultheiss T E
Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy.
The cancer journal from Scientific American 1999;5(3):152-8.
1999: Iyer R V; Hanlon A L; Pinover W H; Hanks G E
Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy.
Cancer 1999;85(8):1816-21.
1999: Bruner D W; Baffoe-Bonnie A; Miller S; Diefenbach M; Tricoli J V; Daly M; Pinover W; Grumet S C; Stofey J; Ross E; Raysor S; Balshem A; Malick J; Engstrom P; Hanks G E; Mirchandani I
Prostate cancer risk assessment program. A model for the early detection of prostate cancer.
Oncology (Williston Park, N.Y.) 1999;13(3):325-34; discussion 337-9, 343-4 pas.
1999: Lattanzi J; McNeeley S; Pinover W; Horwitz E; Das I; Schultheiss T E; Hanks G E
A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer.
International journal of radiation oncology, biology, physics 1999;43(4):719-25.
1999: Herold D M; Hanlon A L; Hanks G E
Diabetes mellitus: a predictor for late radiation morbidity.
International journal of radiation oncology, biology, physics 1999;43(3):475-9.
1999: Eifel P J; Moughan J; Owen J; Katz A; Mahon I; Hanks G E
Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
International journal of radiation oncology, biology, physics 1999;43(2):351-8.
1999: Movsas B; Chapman J D; Horwitz E M; Pinover W H; Greenberg R E; Hanlon A L; Iyer R; Hanks G E
Hypoxic regions exist in human prostate carcinoma.
Urology 1999;53(1):11-8.
1999: Horwitz E M; Hanlon A L; Pinover W H; Hanks G E
Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?
Radiation oncology investigations 1999;7(4):249-59.
1999: Algan O; Pinover W H; Hanlon A L; Al-Saleem T I; Hanks G E
Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?
Radiation oncology investigations 1999;7(2):106-10.
1998: Hanlon A L; Hanks G E
Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer.
Urology 1998;52(5):735-8.
1998: Green G A; Hanlon A L; Al-Saleem T; Hanks G E
A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy.
Cancer 1998;83(5):971-6.
1998: Wurzer J C; Al-Saleem T I; Hanlon A L; Freedman G M; Patchefsky A; Hanks G E
Histopathologic review of prostate biopsies from patients referred to a comprehensive cancer center: correlation of pathologic findings, analysis of cost, and impact on treatment.
Cancer 1998;83(4):753-9.
1998: Coia L R; Minsky B D; John M J; Haller D; Landry J; Pisansky T M; Willet C G; Mahon I; Owen J; Hanks G E
Patterns of care study decision tree and management guidelines for esophageal cancer. American College of Radiology.
Radiation medicine 1998;16(4):321-7.
1998: Anderson P R; Hanlon A L; Patchefsky A; Al-Saleem T; Hanks G E
Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy.
International journal of radiation oncology, biology, physics 1998;41(5):1087-92.
1998: Lattanzi J; McNeely S; Hanlon A; Das I; Schultheiss T E; Hanks G E
Daily CT localization for correcting portal errors in the treatment of prostate cancer.
International journal of radiation oncology, biology, physics 1998;41(5):1079-86.
1998: Hanlon A L; Moore D F; Hanks G E
Modeling postradiation prostate specific antigen level kinetics: predictors of rising postnadir slope suggest cure in men who remain biochemically free of prostate carcinoma.
Cancer 1998;83(1):130-4.
1998: Horwitz E M; Hanlon A L; Pinover W H; Hanks G E
The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy.
International journal of radiation oncology, biology, physics 1998;41(3):519-23.
1998: Hanks G E; Hanlon A L; Schultheiss T E; Pinover W H; Movsas B; Epstein B E; Hunt M A
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.
International journal of radiation oncology, biology, physics 1998;41(3):501-10.
1998: Herold D M; Hanlon A L; Movsas B; Hanks G E
Age-related prostate cancer metastases.
Urology 1998;51(6):985-90.
1998: Movsas B; Hanlon A L; Pinover W; Hanks G E
Is there an increased risk of second primaries following prostate irradiation?
International journal of radiation oncology, biology, physics 1998;41(2):251-5.
1998: Chapman J D; Engelhardt E L; Stobbe C C; Schneider R F; Hanks G E
Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(3):229-37.
1998: Hanks G E; Buzydlowski J; Sause W T; Emami B; Rubin P; Parsons J A; Russell A H; Byhardt R W; Earle J D; Pilepich M V
Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06.
International journal of radiation oncology, biology, physics 1998;40(4):765-8.
1997: Anderson P R; Hanlon A L; Movsas B; Hanks G E
Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation.
International journal of radiation oncology, biology, physics 1997;39(5):1025-30.
1997: Movsas B; Hanlon A L; Teshima T; Hanks G E
Analyzing predictive models following definitive radiotherapy for prostate carcinoma.
Cancer 1997;80(6):1093-102.
1997: Owen J B; Coia L R; Hanks G E
The structure of radiation oncology in the United States in 1994.
International journal of radiation oncology, biology, physics 1997;39(1):179-85.
1997: Teshima T; Hanks G E; Hanlon A L; Peter R S; Schultheiss T E
Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity.
International journal of radiation oncology, biology, physics 1997;39(1):77-83.
1997: Lawton C A; Winter K; Byhardt R; Sause W T; Hanks G E; Russell A H; Rotman M; Porter A; McGowan D G; DelRowe J D; Pilepich M V
Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group.
International journal of radiation oncology, biology, physics 1997;38(5):931-9.
1997: Hanks G E; Hanlon A L; Schultheiss T E; Freedman G M; Hunt M; Pinover W H; Movsas B
Conformal external beam treatment of prostate cancer.
Urology 1997;50(1):87-92.
1997: Lattanzi J P; Hanlon A L; Hanks G E
Early stage prostate cancer treated with radiation therapy: stratifying an intermediate risk group.
International journal of radiation oncology, biology, physics 1997;38(3):569-73.
1997: Kagawa K; Lee W R; Schultheiss T E; Hunt M A; Shaer A H; Hanks G E
Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy.
International journal of radiation oncology, biology, physics 1997;38(2):319-25.
1997: Hanlon A L; Schultheiss T E; Hunt M A; Movsas B; Peter R S; Hanks G E
Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.
International journal of radiation oncology, biology, physics 1997;38(1):59-63.
1997: Pilepich M V; Caplan R; Byhardt R W; Lawton C A; Gallagher M J; Mesic J B; Hanks G E; Coughlin C T; Porter A; Shipley W U; Grignon D
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1013-21.
1997: Hanks G E; Schultheiss T E; Hanlon A L; Hunt M; Lee W R; Epstein B E; Coia L R
Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study.
International journal of radiation oncology, biology, physics 1997;37(3):543-50.
1997: Schultheiss T E; Lee W R; Hunt M A; Hanlon A L; Peter R S; Hanks G E
Late GI and GU complications in the treatment of prostate cancer.
International journal of radiation oncology, biology, physics 1997;37(1):3-11.
1997: Lee W R; Hanks G E; Hanlon A
Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):230-8.
1997: Bonin S R; Hanlon A L; Lee W R; Movsas B; al-Saleem T I; Hanks G E
Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy.
Cancer 1997;79(1):75-80.
1997: Hanks G E; Hanlon A L; Pinover W H; al-Saleem T I; Schultheiss T E
Radiation therapy as treatment for stage T1c prostate cancers.
World journal of urology 1997;15(6):369-72.
1997: Lattanzi J P; Fein D A; McNeeley S W; Shaer A H; Movsas B; Hanks G E
Computed tomography-magnetic resonance image fusion: a clinical evaluation of an innovative approach for improved tumor localization in primary central nervous system lesions.
Radiation oncology investigations 1997;5(4):195-205.
1996: Lau H Y; Kagawa K; Lee W R; Hunt M A; Shaer A H; Hanks G E
Short communication: CT-MRI image fusion for 3D conformal prostate radiotherapy: use in patients with altered pelvic anatomy.
The British journal of radiology 1996;69(828):1165-70.
1996: Algan O; Stobbe C C; Helt A M; Hanks G E; Chapman J D
Radiation inactivation of human prostate cancer cells: the role of apoptosis.
Radiation research 1996;146(3):267-75.
1996: Lee W R; Hanlon A L; Hanks G E
Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival.
The Journal of urology 1996;156(2 Pt 1):450-3.
1996: Hanks G E; Lee W R; Hanlon A L; Hunt M; Kaplan E; Epstein B E; Movsas B; Schultheiss T E
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML.
International journal of radiation oncology, biology, physics 1996;35(5):861-8.
1996: Lee W R; Schultheiss T E; Hanlon A L; Hanks G E
Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer.
Urology 1996;48(1):95-9.
1996: Lee W R; Hanlon A; Hanks G E
Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone?
Urology 1996;47(5):704-7.
1996: Lee W R; Hanks G E; Hanlon A L; Schultheiss T E; Hunt M A
Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
International journal of radiation oncology, biology, physics 1996;35(2):251-7.
1996: Freedman G M; Hanlon A L; Lee W R; Hanks G E
Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation.
International journal of radiation oncology, biology, physics 1996;35(2):243-50.
1996: Hanks G E; Hanlon A L; Hudes G; Lee W R; Suasin W; Schultheiss T E
Patterns-of-failure analysis of patients with high pretreatment prostate-specific antigen levels treated by radiation therapy: the need for improved systemic and locoregional treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1093-7.
1996: Pinover W H; Hanlon A; Lee W R; Kaplan E J; Hanks G E
Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
Cancer 1996;77(7):1334-41.
1996: Fein D A; McGee K P; Schultheiss T E; Fowble B L; Hanks G E
Intra- and interfractional reproducibility of tangential breast fields: a prospective on-line portal imaging study.
International journal of radiation oncology, biology, physics 1996;34(3):733-40.
1996: Hanks G E; Hanlon A L; Lee W R; Slivjak A; Schultheiss T E
Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior.
International journal of radiation oncology, biology, physics 1996;34(3):549-53.
1996: Lee W R; Hanlon A L; Hanks G E
Systematic biopsies: do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone?
Radiology 1996;198(2):439-42.
1996: Teshima T; Owen J B; Hanks G E; Sato S; Tsunemoto H; Inoue T
A comparison of the structure of radiation oncology in the United States and Japan.
International journal of radiation oncology, biology, physics 1996;34(1):235-42.
1996: Bonin S R; Lanciano R M; Corn B W; Hogan W M; Hartz W H; Hanks G E
Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy.
International journal of radiation oncology, biology, physics 1996;34(1):167-72.
1995: Algan O; Hanks G E; Shaer A H
Localization of the prostatic apex for radiation treatment planning.
International journal of radiation oncology, biology, physics 1995;33(4):925-30.
1995: Teshima T; Hanlon A M; Hanks G E
Pretreatment prostate-specific antigen values in patients with prostate cancer: 1989 patterns of care study process survey.
International journal of radiation oncology, biology, physics 1995;33(4):809-14.
1995: Yeh K A; Biade S; Lanciano R M; Brown D Q; Fenning M C; Babb J S; Hanks G E; Chapman D C
Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility.
International journal of radiation oncology, biology, physics 1995;33(1):111-8.
1995: Hanks G E; Lee W R; Schultheiss T E
Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation.
The Journal of urology 1995;154(2 Pt 1):456-9.
1995: Avizonis V N; Buzydlowski J; Lanciano R; Owens J C; Noyes R D; Hanks G E
Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: a phase II study from Radiation Therapy Oncology Group 85-04.
Annals of surgical oncology 1995;2(4):295-302.
1995: Algan O; Coia L R; Keller S M; Engstrom P F; Weiner L M; Schultheiss T E; Hanks G E
Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
International journal of radiation oncology, biology, physics 1995;32(3):753-61.
1995: Schultheiss T E; Hanks G E; Hunt M A; Lee W R
Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate.
International journal of radiation oncology, biology, physics 1995;32(3):643-9.
1995: Corn B W; Hanks G E; Lee W R; Bonin S R; Hudes G; Schultheiss T
Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy.
The Journal of urology 1995;153(6):1855-9.
1995: Corn B W; Hanks G E; Schultheiss T E; Hunt M A; Lee W R; Coia L R
Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment.
International journal of radiation oncology, biology, physics 1995;32(2):325-30.
1995: Hunt M A; Schultheiss T E; Desobry G E; Hakki M; Hanks G E
An evaluation of setup uncertainties for patients treated to pelvic sites.
International journal of radiation oncology, biology, physics 1995;32(1):227-33.
1995: Corn B W; Hanks G E; Lee W R; Schultheiss T
Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance?
Urology 1995;45(3):484-9, discussion489-90.
1995: Hanks G E
The effects of health care reform on academic medical centers: 1994 Gold Medal Address.
International journal of radiation oncology, biology, physics 1995;31(4):999-1004.
1995: Sauter E R; Coia L R; Eisenberg B L; Hanks G E
Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy.
International journal of radiation oncology, biology, physics 1995;31(3):567-9.
1995: Lee W R; Hanks G E; Schultheiss T E; Corn B W; Hunt M A
Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):464-9.
1995: Hanks G E; Schultheiss T E; Hunt M A; Epstein B
Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer.
International journal of radiation oncology, biology, physics 1995;31(1):25-9.
1995: McGee K P; Das I J; Fein D A; Martin E E; Schultheiss T E; Hanks G E
Picture archiving and communications systems in radiation oncology (PACSRO): tools for a physician-based digital image review system.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;34(1):54-62.
1995: Lee W R; Hanks G E; Corn B W; Schultheiss T E
Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy.
International journal of radiation oncology, biology, physics 1995;31(1):21-4.
1994: Shipley W U; Zietman A L; Hanks G E; Coen J J; Caplan R J; Won M; Zagars G K; Asbell S O
Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor.
The Journal of urology 1994;152(5 Pt 2):1799-805.
1994: Lee W R; Giantonio B; Hanks G E
Prostate cancer.
Current problems in cancer 1994;18(6):295-357.
1994: Hanks G E; Hanlon A; Schultheiss T; Corn B; Shipley W U; Lee W R
Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation.
The Journal of urology 1994;152(5 Pt 2):1775-80.
1994: Hanks G E; Hanlon A; Owen J B; Schultheiss T E
Patterns of radiation treatment of elderly patients with prostate cancer.
Cancer 1994;74(7 Suppl):2174-7.
1994: Hanks G E; Perez C A; Kozar M; Asbell S O; Pilepich M V; Pajak T F
PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation.
International journal of radiation oncology, biology, physics 1994;30(2):289-92.
1994: Machtay M; Lanciano R; Hoffman J; Hanks G E
Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma.
International journal of radiation oncology, biology, physics 1994;30(1):43-8.
1994: Corn B W; Hanlon A L; Pajak T F; Owen J; Hanks G E
Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix.
Gynecologic oncology 1994;53(3):294-300.
1994: Corn B W; Lanciano R M; Greven K M; Noumoff J; Schultz D; Hanks G E; Fowble B L
Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):510-5.
1994: Hanks G E; Krall J M; Hanlon A L; Asbell S O; Pilepich M V; Owen J B
Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure.
International journal of radiation oncology, biology, physics 1994;28(1):39-45.
1994: Hanks G E
Treatment of early stage prostate cancer: radiotherapy.
Important advances in oncology 1994;():225-39.
1993: Bruner D W; Lanciano R; Keegan M; Corn B; Martin E; Hanks G E
Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma.
International journal of radiation oncology, biology, physics 1993;27(4):825-30.
1993: D'Amico A V; Hanks G E
Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer.
Cancer 1993;72(9):2638-43.
1993: Hanks G E; D'Amico A; Epstein B E; Schultheiss T E
Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time.
International journal of radiation oncology, biology, physics 1993;27(1):125-7.
1993: Herbert S H; Solin L J; Hoffman J P; Schultz D J; Curran W J; Lanciano R M; Rosenblum N; Hogan M; Eisenberg B; Hanks G E
Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander.
International journal of radiation oncology, biology, physics 1993;25(5):885-93.
1993: Lanciano R M; Pajak T F; Martz K; Hanks G E
The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.
International journal of radiation oncology, biology, physics 1993;25(3):391-7.
1993: Coia L R; Soffen E M; Schultheiss T E; Martin E E; Hanks G E
Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy.
Cancer 1993;71(2):281-6.
1992: Noyes R D; Weiss S M; Krall J M; Sause W T; Owens J R; Wolkov H B; Lanciano R; Hanks G E; Hoffmann J
Surgical complications of intraoperative radiation therapy: the Radiation Therapy Oncology Group experience.
Journal of surgical oncology 1992;50(4):209-15.
1992: Wolkov H B; Graves G M; Won M; Sause W T; Byhardt R W; Hanks G E
Intraoperative radiation therapy of extrahepatic biliary carcinoma: a report of RTOG-8506.
American journal of clinical oncology 1992;15(4):323-7.
1992: Epstein B E; Hanks G E
Prostate cancer: evaluation and radiotherapeutic management.
CA: a cancer journal for clinicians 1992;42(4):223-40.
1992: Greven K M; Spera J A; Solin L J; Morgan T; Hanks G E
Local recurrence after cystectomy alone for bladder carcinoma.
Cancer 1992;69(11):2767-70.
1992: Lanciano R M; Martz K; Montana G S; Hanks G E
Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study.
Cancer 1992;69(8):2124-30.
1992: Chu J C; Stafford P M; Hanks G E; Peters L
Use of computerized hot wire block cutter in radiation therapy.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1992;17(1):11-3.
1992: Greven K M; Spera J A; Solin L J; Whittington R; Wein A J; Hanks G E
Secondary malignant neoplasms in patients with bladder carcinoma.
Urology 1992;39(3):204-6.
1992: Hanks G E
External beam radiation treatment for prostate cancer: still the gold standard.
Oncology (Williston Park, N.Y.) 1992;6(3):79-86, 89; discussion 90-4.
1992: Lanciano R M; Won M; Hanks G E
A reappraisal of the International Federation of Gynecology and Obstetrics staging system for cervical cancer. A study of patterns of care.
Cancer 1992;69(2):482-7.
1992: Rosenthal S A; Yeung R S; Weese J L; Eisenberg B L; Hoffman J P; Coia L R; Hanks G E
Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy. A report of a phase I-II trial.
Cancer 1992;69(2):335-41.
1992: Hanks G E; Krall J M; Pilepich M V; Asbell S O; Perez C A; Rubin P; Sause W T; Doggett R L
Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification.
International journal of radiation oncology, biology, physics 1992;23(2):293-8.
1992: Hanks G E
The crisis in health care cost in the United States: some implications for radiation oncology.
International journal of radiation oncology, biology, physics 1992;23(1):203-6.
1992: Hanks G E; Maher E J; Coia L
An overview of the First International Consensus Workshop on Radiation Therapy in the Treatment of Metastatic and Locally Advanced Cancer.
International journal of radiation oncology, biology, physics 1992;23(1):201.
1992: Corn B W; Lanciano R M; Greven K M; Schultz D J; Reisinger S A; Stafford P M; Hanks G E
Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure.
International journal of radiation oncology, biology, physics 1992;24(2):223-7.
1992: Chu J C; Solin L J; Hwang C C; Kessler H; Hanks G E
Three-dimensional dosimetric comparison of radiation therapy treatment planning of the pancreas.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1992;17(4):199-203.
1992: Soffen E M; Hanks G E; Hunt M A; Epstein B E
Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity.
International journal of radiation oncology, biology, physics 1992;24(3):485-8.
1991: Corn B W; Coia L R; Chu J C; Hwang C C; Stafford P M; Hanks G E
Significance of prone positioning in planning treatment for esophageal cancer.
International journal of radiation oncology, biology, physics 1991;21(5):1303-9.
1991: Tepper J E; Noyes D; Krall J M; Sause W T; Wolkov H B; Dobelbower R R; Thomson J; Owens J; Hanks G E
Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Radiation Therapy Oncology Group.
International journal of radiation oncology, biology, physics 1991;21(5):1145-9.
1991: Lawton C A; Won M; Pilepich M V; Asbell S O; Shipley W U; Hanks G E; Cox J D; Perez C A; Sause W T; Doggett S R
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.
International journal of radiation oncology, biology, physics 1991;21(4):935-9.
1991: Hanks G E; Asbell S; Krall J M; Perez C A; Doggett S; Rubin P; Sause W; Pilepich M V
Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06.
International journal of radiation oncology, biology, physics 1991;21(4):1099-103.
1991: Stafford P M; Martin E E; Chu J C; Davidson B A; Hanks G E
Digital imaging in the radiation oncology environment: a personal computer local area network solution.
Journal of digital imaging : the official journal of the Society for Computer Applications in Radiology 1991;4(3):177-84.
1991: Herbert S H; Solin L J; Rate W R; Schultz D J; Hanks G E
The effect of palliative radiation therapy on epidural compression due to metastatic malignant melanoma.
Cancer 1991;67(10):2472-6.
1991: Herbert S H; Curran W J; Solin L J; Stafford P M; Lanciano R M; Hanks G E
Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation.
International journal of radiation oncology, biology, physics 1991;20(4):835-42.
1991: Lanciano R M; Won M; Coia L R; Hanks G E
Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies.
International journal of radiation oncology, biology, physics 1991;20(4):667-76.
1991: Lanciano R M; Martz K; Coia L R; Hanks G E
Tumor and treatment factors improving outcome in stage III-B cervix cancer.
International journal of radiation oncology, biology, physics 1991;20(1):95-100.
1991: Goldwein J W; Coia L R; Hanks G E
Prognostic factors in patients with early stage non-Hodgkin's lymphomas of the head and neck treated with definitive irradiation.
International journal of radiation oncology, biology, physics 1991;20(1):45-51.
1991: Soffen E M; Hanks G E; Hwang C C; Chu J C
Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization.
International journal of radiation oncology, biology, physics 1991;20(1):141-6.
1991: Solin L J; Fowble B L; Martz K L; Goodman R L; Hanks G E
Results of the 1983 patterns of care process survey for definitive breast irradiation.
International journal of radiation oncology, biology, physics 1991;20(1):105-11.
1991: Markiewicz D; Hanks G E
Therapeutic options in the management of incidental carcinoma of the prostate.
International journal of radiation oncology, biology, physics 1991;20(1):153-67.
1991: Coia L R; Engstrom P F; Paul A R; Stafford P M; Hanks G E
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
International journal of radiation oncology, biology, physics 1991;20(1):29-36.
1990: Lanciano R M; Curran W J; Greven K M; Fanning J; Stafford P; Randall M E; Hanks G E
Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium.
Gynecologic oncology 1990;39(3):368-73.
1990: Chu J C; Solin L J; Hwang C C; Fowble B; Hanks G E; Goodman R L
A nondivergent three field matching technique for breast irradiation.
International journal of radiation oncology, biology, physics 1990;19(4):1037-40.
1990: Keidan R D; Hoffman J P; Weese J L; Hanks G E; Solin L J; Eisenberg B L; Ottery F D; Boraas M
Delayed breast abscesses after lumpectomy and radiation therapy.
The American surgeon 1990;56(7):440-4.
1990: Soffen E M; Solin L J; Rubenstein J H; Hanks G E
Palliative radiotherapy for symptomatic adrenal metastases.
Cancer 1990;65(6):1318-20.
1990: Greven K M; Solin L J; Hanks G E
Prognostic factors in patients with bladder carcinoma treated with definitive irradiation.
Cancer 1990;65(4):908-12.
1989: Chu J C; Stafford P M; Diamond J J; Won M; Hanks G E
Equipment and manpower needs in radiation oncology dosimetry and treatment delivery.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1989;14(4):265-7.
1989: Chu J C; Stafford P M; Diamond J J; Lee M; Hanks G E
Patterns of change in the physics and technical support of radiation therapy in the USA 1975-1986.
International journal of radiation oncology, biology, physics 1989;17(2):437-42.
1989: Hanks G E
Quality assurance in radiation oncology in the United States 1988.
Cancer 1989;64(1 Suppl):223-5; discussion 240-3.
1989: Hanks G E; Edland R W; Diamond J J
Variation in the technical support of radiation oncology in different practice settings.
International journal of radiation oncology, biology, physics 1989;16(6):1583-6.
1989: Hanks G E; Martz K L; Krall J M; Diamond J J
Analysis of independent variables affecting survival after recurrence of prostate cancer.
International journal of radiation oncology, biology, physics 1989;16(6):1431-5.
1989: Hanks G E
Treatment of locally advanced prostate cancer with radiation therapy.
Urology 1989;33(5 Suppl):37-41.
1989: Hanks G E
External beam radiation therapy for prostate cancer clinically confined to the gland.
Urology 1989;33(5 Suppl):21-6.
1988: Hanks G E; Martz K L; Diamond J J
The effect of dose on local control of prostate cancer.
International journal of radiation oncology, biology, physics 1988;15(6):1299-305.
1988: Sandler H M; Hanks G E
Analysis of the possibility that transurethral resection promotes metastasis in prostate cancer.
Cancer 1988;62(12):2622-7.
1988: Coia L R; Hanks G E
Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma.
International journal of radiation oncology, biology, physics 1988;15(1):29-35.
1988: Hanks G E
Quality control and assurance.
American journal of clinical oncology 1988;11(3):411-4.
1988: Hanks G E
Radical prostatectomy or radiation therapy for early prostate cancer. Two roads to the same end.
Cancer 1988;61(11):2153-60.
1988: Coia L R; Hanks G E; Martz K; Steinfeld A; Diamond J J; Kramer S
Practice patterns of palliative care for the United States 1984-1985.
International journal of radiation oncology, biology, physics 1988;14(6):1261-9.
1988: Hanks G E; Krall J M; Martz K L; Diamond J J; Kramer S
The outcome of treatment of 313 patients with T-1 (UICC) prostate cancer treated with external beam irradiation.
International journal of radiation oncology, biology, physics 1988;14(2):243-8.
1987: Hanks G E
Quality assurance in the EORTC and implications for cooperative studies with the RTOG.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1987;10(1):77-9.
1987: Hanks G E; Diamond J J; Krall J M; Martz K L; Kramer S
A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States.
International journal of radiation oncology, biology, physics 1987;13(4):499-505.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Gerald Hanks

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Gerald Hanks (preview)

All Publications